Gynecology Research Unit, Hannover Medical School, Hannover, Germany.
Breast Cancer Res Treat. 2011 Apr;126(2):545-50. doi: 10.1007/s10549-010-1290-4. Epub 2010 Dec 17.
Since germline mutations in the PALB2 (Partner and Localizer of BRCA2) gene have been identified as breast cancer (BC) susceptibility alleles, the geographical spread and risks associated with PALB2 mutations are subject of intense investigation. Patients with bilateral breast cancer constitute a valuable group for genetic studies. We have thus scanned the whole coding region of PALB2 in a total of 203 German or Russian bilateral breast cancer patients using an approach based on high-resolution melting analysis and direct sequencing of genomic DNA samples. Truncating PALB2 mutations were identified in 4/203 (2%) breast cancer patients with bilateral disease. The two nonsense mutations, p.E545X and p.Q921X, have not been previously described whereas the two other mutations, p.R414X and c.509_510delGA, are recurrent. Our results indicate that PALB2 germline mutations account for a small, but not negligible, proportion of bilateral breast carcinomas in German and Russian populations.
由于 PALB2(BRCA2 伴侣和定位子)基因的种系突变已被确定为乳腺癌(BC)易感等位基因,因此 PALB2 突变的地理分布和相关风险是深入研究的主题。双侧乳腺癌患者是遗传研究的有价值群体。因此,我们使用基于高分辨率熔解分析和直接测序基因组 DNA 样本的方法,在总共 203 名德国或俄罗斯双侧乳腺癌患者中扫描了 PALB2 的整个编码区。在 4/203(2%)双侧疾病的乳腺癌患者中发现了截断的 PALB2 突变。这两个无意义突变,p.E545X 和 p.Q921X,以前没有描述过,而另外两个突变,p.R414X 和 c.509_510delGA,是复发性的。我们的结果表明,PALB2 种系突变在德国和俄罗斯人群中占双侧乳腺癌的一小部分,但并非微不足道。